DFX Intelligence
The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
G••••• C••••••••
Single family office (confirmed)Top 500· Aspen, CO
Single family office (confirmed), based in Aspen, CO, with 18 direct investments on record.
Composed from this office's classification, location and record.
As of · the latest observation of this office; filed figures carry their own filing dates
- Direct investments
- 18
- Decision makers
- 3 of 8
- Last deployment
- 2014
Deal announcements, Form D and filings
The office's site, Form ADV Schedule A and filings
The latest dated investment or commitment on record
As of · the latest observation of this office; filed figures carry their own filing dates
Nothing material in the last 365 days. Last change: 15 Sep 2026, ••• Locked.
Readings, classification basis and verificationidentity confidence 80% · 21 observations · 3 sourcesShowHide
Single family office (confirmed)Verified Sep 16, 2026 (8 days ago)8 people · 18 investments · 0 public positions · 4 events
Why this class: The firm's own w•••••• states it is a healthcare-focused Single Family Office and, on the same page, credits S•••• G••••• as the person who has built the firm's companies for 45+ years.
Direct investing
70
high
Co-investment
100
high
Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, private markets, sponsor-friendly, real estate.
Profile completeness 59% (high value, high value deep; the most valuable missing fact is fund relationships)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
Overviewshow
- Classification
- Single family office (confirmed)
- Description
- ••• Locked
- Headquarters
- ••• Locked
- Office address
- unknown
- Business phone
- unknown
- Website
- g•••••••••.com
- Year established
- unknown
- Assets under management
- unknown
- Capital scale
- Reported office AUM: unknown. No public number of any kind.
Classification history
- Sep 15, 2026Single family office (confirmed) 80%The firm's own w•••••• states it is a healthcare-focused Single Family Office and, on the same page, credits S•••• G••••• as the person who has built the firm's companies for 45+ yearsFactverifiedg•••••••••.com“••• Locked”
- Sep 14, 2026Single family office (probable) 70%a filing by a third party describes it as a single family office (cited)Fact
- Sep 14, 2026Candidate 25%no rule matched; held as a candidate pending researchInference
Family and wealth originshow
- Family served
- G••••• family
- Source of wealth
- ••• Locked
- Operating company origin
- unknown
Team8 people, 3 with investment decisions, decision makers firstshow
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| E•••• U•••••• | Managing Partner | Chief investment officer · investment decisions | none on record | g•••••••••.com Fact |
| M••• G••••• family | Entrepreneur (son of founder) | Family principal · investment decisions | none on record | g•••••••••.com Fact |
| S•••• G••••• family | Principal & Founder | Family principal · investment decisions | none on record | g•••••••••.com Fact |
| F••••••• P••••••••• | Director Emeritus | Board | none on record | g•••••••••.com Fact |
| S•••• C•••• | Executive Partner | Leadership | none on record | g•••••••••.com Fact |
Full team · 8 peopleShow fewerdecision makers first
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| J••• T••••• | CFO | Operations and finance | none on record | g•••••••••.com Fact |
| J••• M•••••• | Defense Science & Technology Advisor | Other | none on record | g•••••••••.com Fact |
| M•••••• M•••••• | Chief Science Officer | Other | none on record | g•••••••••.com Fact |
1 former personShow fewer
J•••• C•••••, Managing Partner, until Sep 16, 2026
Signals and timeline4show
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 4 events. 13F position changes are under Public stakes and holdings.
- Mar 30, 2018Office discovered••• LockedDiscoveryFactsec.gov
- Sep 15, 2026Classification changed••• Lockedc•••••••••Factg•••••••••.com
- Sep 14, 2026Classification changed••• Lockedc•••••••••Factno URL
- Jan 1, 2014Portfolio exit••• LockedDirect investmentsFactg•••••••••.com
Investment mandateshow
••• Locked
Stated (their words, cited)
No cited statement of mandate on the record.
Observed (from the investment record)
- States
- none Fact
- Control
- unknown (18) Fact
- Sectors
- cell-based cancer therapy (1), anti-angiogenesis technology (1), peptide therapeutics / senescence (1), small business loans (1), small-molecule epigenetic therapeutics (1), minimally invasive surgical platforms (1), palladium implants for prostate cancer (1), private probation services (1) Fact
- Subsectors
- none Fact
- Co investors
- M••• G••••• (2), D•• A•• R••••• (1), P••• Z••••••••• (1), J•••• S••••••• (1), D•• D•••• H••• (1) Fact
- Asset classes
- biotech (14), fintech (1), services (1), technology (1), environmental (1) Fact
- Direct vs fund
- Fund: 0 · Direct: 18 · Real estate: 0 Fact
- Sponsors backed
- none Fact
- Investment count
- 18 Fact
- Investment kinds
- direct equity (exited) (9), direct equity (7), direct equity (exited, as Chairman) (1), direct equity / spinout (1) Fact
- First and last deal
- Last: unknown · First: unknown Fact
- Lead vs participant
- lead (16), participant (2) Fact
- Disclosed check sizes
- Max: $14B · Min: $200,000 · Count: 11 Fact••• Locked
Inferred (regulatory shape and team)
Nothing to infer from.
- Invests directly
- unknown
- Allocates to managers
- unknown
- Asset classes
- unknown
- Sectors
- unknown
- Geography
- unknown
- Check size
- unknown
Direct investments17 dealsshow
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Date not disclosed | K•••••• | Direct equity (exited) | small business loans | participant | $875M | M••• G••••• (co investor) | g•••••••••.com Fact “••• Locked” |
| Date not disclosed exit Jan 1, 2014 | J••••••• C••••••••• S••••••• | Direct equity (exited) | private probation services | participant | unknown | M••• G••••• (co investor) | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | P••••• G••• P••••••• I••• | Direct equity (exited) | encryption software | lead | $38.0M | P••• Z••••••••• (co investor) | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | P•••••••• E••••••••• S••••••• | Direct equity (exited) | nuclear waste cleanup | lead | $100M | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | D••• B••••••••• | Direct equity | neuropathic pain and cancer treatment | lead | $800,000 | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | M••••• | Direct equity | tissue regeneration | lead | $1.1B | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | M••••••••• I••• | Direct equity (exited) | prostate cancer drugs | lead | $14B | D•• D•••• H••• (co investor), D•• A•• R••••• (co investor) | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | E••••••• | Direct equity (exited, as Chairman) | anti-angiogenesis technology | lead | $1.4B | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | M•••••• P••••••••• C••••••••• | Direct equity (exited) | dermatology | lead | $2.7B | J•••• S••••••• (co investor) | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | C•••• C••••••••• | Direct equity (exited) | cardiovascular / blood flow products | lead | $200,000 | none named | g•••••••••.com Fact “••• Locked” |
All 17 investmentsShow fewermost recent first
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Date not disclosed | T••••••••• C••••••••• | Direct equity (exited) | palladium implants for prostate cancer | lead | $1.0B | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | H•••• B••••••••• | Direct equity (exited) | monoclonal antibodies / diagnostics | lead | $100M | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | I••••••• | Direct equity / spinout | medical device / infection control | lead | unknown | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | O•••• I••• | Direct equity | small-molecule epigenetic therapeutics | lead | unknown | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | S•••• | Direct equity | peptide therapeutics / senescence | lead | unknown | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | C•••••• T••••••••• I••• | Direct equity | antimicrobial polymers / air filtration | lead | unknown | none named | g•••••••••.com Fact “••• Locked” |
| Date not disclosed | C••••••• I••• | Direct equity | cell-based cancer therapy | lead | unknown | none named | g•••••••••.com Fact “••• Locked” |
Fund and manager relationshipsshow
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdingsshow
Form 13F holdings
No 13F filing on the record for this office.
Real estateshow
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors5show
| Counterparty | Kind | Shared deals | First, last | Examples | Source |
|---|---|---|---|---|---|
| M••• G••••• | organisation | 2 | undated (historical) | J••••••• C••••••••• S•••••••, K•••••• | g•••••••••.com |
| D•• A•• R••••• | organisation | 1 | undated (historical) | M•• I••••••••• | g•••••••••.com |
| D•• D•••• H••• | organisation | 1 | undated (historical) | M••••••••• I••• | g•••••••••.com |
| J•••• S••••••• | organisation | 1 | undated (historical) | M•••••• P••••••••• C••••••••• | g•••••••••.com |
| P••• Z••••••••• | organisation | 1 | undated (historical) | P••••• G••• P••••••• I••• | g•••••••••.com |
- M••• G••••• strong (3) Fact g•••••••••.com
- M••• G••••• strong (3) Fact g•••••••••.com
- M••• G••••• strong (3) Fact g•••••••••.com
- P••• Z••••••••• recurring (2) Fact g•••••••••.com
- P••• Z••••••••• recurring (2) Fact g•••••••••.com
All 11 co-investment linksShow fewer
- D•• A•• R••••• recurring (2) Fact g•••••••••.com
- D•• A•• R••••• recurring (2) Fact g•••••••••.com
- D•• D•••• H••• recurring (2) Fact g•••••••••.com
- D•• D•••• H••• recurring (2) Fact g•••••••••.com
- J•••• S••••••• recurring (2) Fact g•••••••••.com
- J•••• S••••••• recurring (2) Fact g•••••••••.com
Independent sponsor relationshipsshow
No cited relationship to an independent sponsor.
Related entitiesshow
Sources and evidence21show
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 21 shown.
Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (6 days)
Contactability
+30 n•••• d••••••••• (••• Locked)
+20 v••••••• b••••••• e••••• (2)
+10 v••••••• b••••••• p••••• (1)
Data confidence
+10 w••••••
+10 d•••••••••
+10 p•••••
+15 i•••••••••
+15 i••••••••• s•••••• (3 sources)
Active deployment
no components; scored 0
Exists confidence
+20 w••••••
+30 i••••••••• s•••••• (3 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+15 d••••• i••••••••• o• r•••••
+0 r••• (249)
Mandate confidence
+70 m•••••• s•••••••• b• o••••••• i•••••••••
Identity confidence
+80 c••••••••• (••• Locked)
Real estate propensity
no components; scored 0
Co investment propensity
+80 c••••••••• o• t•• r••••• (••• Locked)
+20 p••••••••• i• s••••••••• r•••••
Family identity confidence
+60 w••••• o••••• o• o•••••••• c•••••• o• t•• r•••••
+40 f••••• n•••• (G••••• family)
+20 f••••• p•••••••• o• s••••
Private markets propensity
no components; scored 0
Current activity confidence
no components; scored 0
External manager propensity
no components; scored 0
Direct investment propensity
+70 o••••••• d••••• i••••••••• (18 on the record)
Independent sponsor propensity
no components; scored 0
View all 21 observationsShow fewer
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Asset allocation stated | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Board participation | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Decision rights | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Description | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Description | ••• Locked “••• Locked” | Aug 21, 2017 | DFX analyst research (General-assisted, every claim URL-cited) globenewswire.com | Fact |
| Edgar fts discovery | family office, single family office | Mar 30, 2018 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Family involvement | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Family served | G••••• family “••• Locked” | n/a | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Headquarters | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Investment committee | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Investment committee | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Investment committee | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Office type (stated) | Single family office “••• Locked” | Sep 15, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Office type (stated) | Single family office | Mar 30, 2018 | SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.gov | Fact |
| Philanthropy program | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Philanthropy program | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Philanthropy program | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Source of wealth | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Source of wealth | ••• Locked “••• Locked” | Sep 16, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Website | ••• Locked “••• Locked” | Sep 15, 2026 | DFX analyst research (General-assisted, every claim URL-cited) g•••••••••.com | Fact |
| Website search | Not found | Sep 14, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
Not yet on record: capital scale.